Pharmacokinetics of single and repeated oral doses of pregabalin oral solution formulation in cats

The study was designed to determine the pharmacokinetic profile and bioavailability of a novel pregabalin 50 mg/ml oral solution formulation (Bonqat(®), Orion Corporation Orion Pharma) in 6 healthy laboratory cats. The cats received pregabalin as single oral doses of 2.5, 5, and 7.5 mg/kg, dose 5 mg...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamminen, Terttu, Doedée, Anne, Hyttilä‐Hopponen, Minja, Kaskinoro, Janne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545034/
https://www.ncbi.nlm.nih.gov/pubmed/35466408
http://dx.doi.org/10.1111/jvp.13061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545034/
https://www.ncbi.nlm.nih.gov/pubmed/35466408
http://dx.doi.org/10.1111/jvp.13061

Ejemplares similares